The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis

BMB Reports

Volumn 47, Issue 8, 2014, Pages 457-462

  Lee, Su Jin ^a   Yoo, Jae Do ^a   Choi, Soo Young ^b   Kwon, Oh Shin ^a  

^a Kyungpook National University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Caspase 3; MCD diet; NASH; Secretion; Vimentin

Indexed keywords

BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE 3; LIPOPOLYSACCHARIDE; PALMITIC ACID DERIVATIVE; PEPTIDE CHLOROMETHYL KETONE; VIMENTIN;

ANIMAL; APOPTOSIS; C57BL MOUSE; DIET; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; PATHOLOGY; UPREGULATION;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASE 3; DIET; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEP G2 CELLS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; PALMITATES; UP-REGULATION; VIMENTIN;

EID: 84906837476     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.8.256     Document Type: Article

References (21)

1. Schreuder, T. C., Verwer, B. J., van Nieuwkerk, C. M. and Mulder, C. J. (2007) Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J. Gastroenterol. 14, 2474-2486.
2. Day, C. P. and James, O. F. (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845.
3. Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. and Tiribelli, C. (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends. Mol. Med. 14, 72-81.
4. Carter-Kent, C., Zein, N. N. and Feldstein, A. E. (2008) Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am. J. Gastroenterol. 103, 1036-1042.
5. Alkhouri, N., Carter-Kent, C. and Feldstein, A. E. (2011) Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert. Rev. Gastroenterol. Hepatol. 5, 201-212.
6. Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, A. R., McCullough, A. J. and Feldstein, A. E. (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44, 27-33.
7. Bantel, H., Ruck, P., Gregor, M. and Schulze-Osthoff, K. (2001) Detection of elevated caspase activation and early apoptosis in liver diseases. Eur. J. Cell Biol. 80, 230-239.
8. Evans, R. M. (1998) Vimentin: the conundrum of the intermediate filament gene family. Bioessays 20, 79-86.
9. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
10. Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K. J. and Cryns, V. L. (2001) Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death. Differ. 8, 443-450.
11. Park, J. E., Kim, H. T., Lee, S., Lee, Y. S., Choi, U. K., Kang, J. H., Choi, S. Y., Kang, T. C., Choi, M. S. and Kwon, O. S. (2011) Differential expression of intermediate filaments in the process of developing hepatic steatosis. Proteomics 11, 2777-2789.
12. Cong, M., Iwaisako, K., Jiang, C. and Kisseleva, T. (2012) Cell signals influencing hepatic fibrosis. Int. J. Hepatol. 2012, 158547.
13. Feldstein, A. E., Wieckowska, A., Lopez, A. R., Liu, Y. C., Zein, N. N. and McCullough, A. J. (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50, 1072-1078.
14. Day, C. P. and James, O. F. (1998) Hepatic steatosis: innocent bystander or guilty party? Hepatology 27, 1463-1466.
15. Seehase, S., Lauenstein, H. D., Schlumbohm, C., Switalla, S., Neuhaus, V., Forster, C., Fieguth, H. G., Pfennig, O., Fuchs, E., Kaup, F. J., Bleyer, M., Hohlfeld, J. M., Braun, A., Sewald, K. and Knauf, S. (2012) LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing. PLoS One 7, e43709.
16. Bhatia, M. and Moochhala, S. (2004) Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 202, 145-156.
17. Park, J. H., Kim, K. H., Lee, W. R., Han, S. M. and Park, K. K. (2012) Protective effect of melittin on inflammation and apoptosis in acute liver failure. Apoptosis 17, 61-69.
18. Caulin, C., Salvesen, G. S. and Oshima, R. G. (1997) Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138, 1379-1394.
19. Rao, L., Perez, D. and White, E. (1996) Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135, 1441-1455.
20. Mor-Vaknin, N, Punturieri, A., Sitwala, K. and Markovitz, D. M. (2003) Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5, 59-63.
21. Xu, B., deWaal, R. M., Mor-Vaknin, N., Hibbard, C., Markovitz, D. M. and Kahn, M. L. (2004) The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell Biol. 24, 9198-9206.